Rosenson RS - Search Results

1

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

Rosenson RS, Tangney CC. Rosenson RS, et al. JAMA. 1998 May 27;279(20):1643-50. doi: 10.1001/jama.279.20.1643. JAMA. 1998. PMID: 9613915 Review.

2

Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.

Rosenson RS, Wolff D, Tangney CC. Rosenson RS, et al. Clin Sci (Lond). 2004 Feb;106(2):215-7. doi: 10.1042/CS20030291. Clin Sci (Lond). 2004. PMID: 12967321 Clinical Trial.

3

Comparative study of HMG-CoA reductase inhibitors on fibrinogen.

Rosenson RS, Tangney CC, Schaefer EJ. Rosenson RS, et al. Atherosclerosis. 2001 Apr;155(2):463-6. doi: 10.1016/s0021-9150(00)00590-6. Atherosclerosis. 2001. PMID: 11254918 Clinical Trial.

4

Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia.

Rosenson RS, Tangney CC, Levine DM, Parker TS, Gordon BR. Rosenson RS, et al. Atherosclerosis. 2004 Nov;177(1):77-81. doi: 10.1016/j.atherosclerosis.2004.05.027. Atherosclerosis. 2004. PMID: 15488868 Clinical Trial.

5

Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects.

Rosenson RS, Tangney CC, Levine DM, Parker TS, Gordon BR. Rosenson RS, et al. J Lab Clin Med. 2005 Feb;145(2):83-7. doi: 10.1016/j.lab.2004.11.012. J Lab Clin Med. 2005. PMID: 15746650 Clinical Trial.

6

Short-term reduction in bone markers with high-dose simvastatin.

Rosenson RS, Tangney CC, Langman CB, Parker TS, Levine DM, Gordon BR. Rosenson RS, et al. Osteoporos Int. 2005 Oct;16(10):1272-6. doi: 10.1007/s00198-005-1897-1. Epub 2005 Aug 9. Osteoporos Int. 2005. PMID: 16088363 Clinical Trial.

7

Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity.

Rosenson RS, Shott S, Tangney CC. Rosenson RS, et al. Atherosclerosis. 2002 Apr;161(2):433-9. doi: 10.1016/s0021-9150(01)00656-6. Atherosclerosis. 2002. PMID: 11888528

8

Alcohol Consumption and Cardiovascular Health.

Krittanawong C, Isath A, Rosenson RS, Khawaja M, Wang Z, Fogg SE, Virani SS, Qi L, Cao Y, Long MT, Tangney CC, Lavie CJ. Krittanawong C, et al. Among authors: rosenson rs. Am J Med. 2022 Oct;135(10):1213-1230.e3. doi: 10.1016/j.amjmed.2022.04.021. Epub 2022 May 14. Am J Med. 2022. PMID: 35580715 Free PMC article.

9

Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size.

Tangney CC, Mosca LJ, Otvos JD, Rosenson RS. Tangney CC, et al. Among authors: rosenson rs. Atherosclerosis. 2001 Apr;155(2):425-30. doi: 10.1016/s0021-9150(00)00577-3. Atherosclerosis. 2001. PMID: 11254913 Clinical Trial.

10

Hypertriglyceridemia and other factors associated with plasma viscosity.

Rosenson RS, Shott S, Lu L, Tangney CC. Rosenson RS, et al. Am J Med. 2001 Apr 15;110(6):488-92. doi: 10.1016/s0002-9343(01)00643-x. Am J Med. 2001. PMID: 11331062 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page